These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1242616)

  • 1. Hydantoin derivatives and malignancies of the haemopoietic system.
    Bichel J
    Acta Med Scand; 1975 Oct; 198(4):327-8. PubMed ID: 1242616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydantoin derivatives and malignancies of the haemopoietic system].
    Bichel J
    Folia Clin Int (Barc); 1976 Oct; 26(10):420-1. PubMed ID: 1036724
    [No Abstract]   [Full Text] [Related]  

  • 3. Adult T-cell lymphoma following diphenylhydantoin therapy.
    Isobe T; Horimatsu T; Fujita T; Miyazaki K; Sugiyama T
    Nihon Ketsueki Gakkai Zasshi; 1980 Aug; 43(4):711-4. PubMed ID: 6784433
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydantoin immunosuppression clinical study.
    Badawy AH; Shalaby SA; Abdel Aal SF
    J Egypt Soc Parasitol; 1991 Apr; 21(1):257-62. PubMed ID: 2033299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.
    Olsen JH; Schulgen G; Boice JD; Whysner J; Travis LB; Williams GM; Johnson FB; McGee JO
    Cancer Res; 1995 Jan; 55(2):294-7. PubMed ID: 7812960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-positive non-Hodgkin's lymphoma developing after phenytoin therapy.
    Garcia-Suarez J; Dominguez-Franjo P; Del Campo F; Herrero B; Munoz MA; Piris MA; Pardo A
    Br J Haematol; 1996 Nov; 95(2):376-9. PubMed ID: 8904896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease following treatment with hydantoins. Report of a case and review of the literature (author's transl)].
    Bladé Creixenti J; Segura Porta F; Nogué Xarau S; Soriano Marín E; García San Miguel J
    Med Clin (Barc); 1980 Jun; 75(1):24-6. PubMed ID: 7392707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new case of the so-called "hydantoin perniciosa"].
    Gottwald W; Henn R
    Med Welt; 1972 Sep; 23(39):1344-8. PubMed ID: 4639576
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lymphadenopathy in phenytoin treatment].
    Marg E; Köpke E; Schillat I
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jul; 30(7):430-6. PubMed ID: 100800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated malignant lymphoma of the jejunum and long-term diphenylhydantoin therapy.
    Rubinstein I; Langevitz P; Shibi G
    Oncology; 1985; 42(2):104-6. PubMed ID: 3887259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is phenytoin carcinogenic?
    Kruger GR; Harris D
    Lancet; 1972 Feb; 1(7745):323. PubMed ID: 4109962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant lymphoma or hydantoin lymphadenopathy? (author's transl)].
    Beil E; Prechtel K
    Munch Med Wochenschr; 1973 Nov; 115(45):2033-9. PubMed ID: 4589193
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lymphadenopathies caused by drugs].
    Krasznai G; Szegedi G
    Orv Hetil; 1969 Nov; 110(48):2797-802. PubMed ID: 4903568
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic hydantoin intoxication: case report.
    Riley CG
    N Z Med J; 1972 Dec; 76(487):425-8. PubMed ID: 4510413
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hydantoin-induced hyperplasia].
    Korff M; Mutschelknauss R
    Dtsch Zahnarztl Z; 1973 Dec; 28(12):1157-63. PubMed ID: 4520580
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential hazards of hydantoin use.
    Easton JD
    Ann Intern Med; 1972 Dec; 77(6):998-9. PubMed ID: 4644176
    [No Abstract]   [Full Text] [Related]  

  • 17. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.
    Gibberd FB; Park DM; Scott G; Gawel MJ; Fry DE; Page NG; Engler C; English JR; Rose FC
    J Neurol Neurosurg Psychiatry; 1982 Dec; 45(12):1113-8. PubMed ID: 6819339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphoma after diphenylhydantoin (dilantin) therapy.
    Li FP; Willard DR; Goodman R; Vawter G
    Cancer; 1975 Oct; 36(4):1359-62. PubMed ID: 1175133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of a benign lymphoepithelial salivary gland lesion to lymphocytic lymphoma during dilantin therapy: correlation with dilantin-induced lymphocyte transformation in vitro.
    Lapes M; Antoniades K; Gartner W; Vivacqua R
    Cancer; 1976 Sep; 38(3):1318-22. PubMed ID: 989031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.